Eric, PYC have RNA drug molecules that are a branch of 'antisense oligonuceotides' (ASO) called Phosphorodiamidate morpholino oligomers (PMO). They attach a cell-penetrating peptide (CPP) and refer to the drug molecule as a CPP-PMO. They are the same family of drugs as Sarepta's PPMOs targeting Duchenne Muscular Dystrophy. eg CPP-PMO = PPMO. PYC are currently targeting faulty RNA within the eye. Sorry for the complexity on a friday night.
PYC Price at posting:
14.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)